December 7, 2018
In a storyline reminiscent of holiday favorite “The Grinch,” the Trump administration seems to be using the season of giving to plot the theft of something Americans hold dear – seniors’ Medicare, in this case.
June 1, 2018
As the global cancer community convenes for the annual meeting of the American Society of Clinical Oncology, one question looms large: What will President Donald Trump’s blueprint to lower drug prices mean for patient access? Especially for cancer patients, who may take several medications or live on a fixed income?
March 26, 2018
Open dialogue is an important part of the drug approval process.
January 23, 2018
Innovative but expensive CAR-T therapies for cancer are worth their price, announced the Institute for Clinical and Economic Review recently. The organization is the self-appointed arbiter of drug costs. But its decision was hardly news for those in the cancer community.
January 16, 2018
Cash-strapped states are exploring a controversial new way to cut Medicaid expenses: limiting which drugs their beneficiaries can access.
January 12, 2018
Nearly 1.7 million Americans learned they had cancer in 2017. Most of these patients began traditional treatments like chemotherapy, radiation and surgery. Yet for many, a groundbreaking new immuno-oncology therapy could have been a better alternative.
October 25, 2017
The British Medical Journal ignited debate earlier this month when it announced that about half of cancer drugs approved by the European Medicines Agency don’t improve survival or quality of life. The claim begs several complex question: How can regulators evaluate drugs both quickly and effectively?
August 29, 2017
Cancer patients are being asked to pay more than they expected for treatment, despite having health insurance.
August 17, 2017
The need for robust clinical trials participation is critical to women and men across this country, whether they know it or not.
August 1, 2017
People are living longer, healthier lives today with the help of advanced medicine. But innovative drugs can be expensive. Insurance…
